04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
The recent antitrust attacks on no-poach clauses encourage insomnia among franchise lawyers. But is ...
Read More >
The Bank of New York Mellon v. Barber, Case No. 1D18-2097 (Fla. 1st DCA 2020). A trial judge may not...
Read More >
The Superintendence of Industry and Commerce (SIC) of Colombia issued Resolution 2103 of 2021, which...
Read More >
Welcome to the newest addition to the Compliance Podcast Network, Compliance and Coronavirus. In thi...
Read More >
California wage laws have taken another alarming departure from federal standards. The highest state...
Read More >
The line between lawful and unlawful unpaid work is not always clear. Many companies are contacted ...
Read More >